2) Epidermal growth factor (EGF)/Epidermal growth factor receptor (EGFR)
表皮生长因子/表皮生长因子受体
4) EGFR gene mutation
表皮生长因子受体(EGFR)基因突变
5) epidermal growth factor receptor (EGFR)
表皮生长因子受体
1.
Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.
表皮生长因子受体(EGFR)基因酪氨酸激酶域体细胞突变与非小细胞肺癌(NSCLC)患者对酪氨酸激酶抑制剂吉非替尼敏感性密切相关。
2.
The epidermal growth factor receptor (EGFR) provides a rational target for cancer therapy as it is commonly overexpressed in a variety of solid tumors, and its deregulation is correlated with resistance to chemotherapy and radiotherapy and a poor prognosis.
在许多肿瘤组织中均有表皮生长因子受体(epidermal growthfactor receptor,EGFR)的过表达,它的失调与肿瘤对化疗和放疗的耐受以及不良预后相关,为肿瘤的治疗提供了一个理想的分子靶点。
3.
The overexpression and inappropriate activation of epidermal growth factor receptor (EGFR) is thought to play an important role in many tumors, especially for the head and neck carcinomas with the overexpression rate of 80%—100%.
表皮生长因子受体(Epidermal Growth Factor Receptor，EGFR)的过度表达和不恰当激活被认为与多种肿瘤的发生发展密切相关，尤其在头颈部肿瘤中EGFR表达上调最普遍，约占80％-100％。
6) epidermal growth factor receptor
表皮生长因子受体
1.
Quantity research on epidermal growth factor in saliva and epidermal growth factor receptor in biopsy samples of recurrent aphthous ulcer patients;
复发性阿弗他溃疡患者唾液中表皮生长因子和病损区表皮生长因子受体的定量研究
2.
Expression and identification of the extracellular domain of human epidermal growth factor receptor type Ⅲ variant;
人表皮生长因子受体Ⅲ型突变体胞外区的克隆表达和鉴定
3.
Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells:a study in tumor-bearing nude mice;
RNAi技术抑制乳腺癌细胞表皮生长因子受体表达的在体实验研究
补充资料：表皮生长因子受体
表皮生长因子受体
为膜受体酪氨酸激酶，因其上有受体分子而表现酶的活性。对其形成的调节机制尚不清楚。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条